Does an Enlarged Prostate Affect Ejaculation?

An enlarged prostate does affect ejaculation, and the problem is far more common than most men realize. In surveys of men with urinary symptoms from benign prostatic hyperplasia (BPH), close to half report some form of ejaculatory trouble, ranging from reduced semen volume and weaker force to retrograde ejaculation, where semen flows backward into the bladder instead of out through the penis. The condition itself, the medications prescribed for it, and the surgical procedures used to treat it can all independently disrupt ejaculation, though through different mechanisms and to very different degrees.

How Common Are Ejaculatory Problems

The numbers are striking. In a comprehensive review of the research, roughly 46 percent of men presenting with lower urinary tract symptoms (the hallmark of BPH) reported ejaculatory dysfunction of some kind.¹ That is not a fringe complaint. And because men often feel uncomfortable bringing up sexual symptoms during a doctor’s visit focused on urinary problems, the real prevalence could be higher. The relationship between urinary symptoms and ejaculatory trouble holds up even after researchers account for age and other health conditions, suggesting that the prostate enlargement itself plays an independent role.²

The specific complaints vary. Some men notice their semen volume has decreased. Others experience weaker ejaculatory force, a delay in reaching ejaculation, or less pleasure during orgasm. And some develop “dry” orgasms, where climax happens but little or no fluid comes out. These are not interchangeable symptoms; they reflect different aspects of the ejaculatory process being disrupted, and a man with BPH might experience one, several, or all of them at different times.

What Actually Goes Wrong

Ejaculation is a surprisingly complicated sequence. Semen is assembled from fluid produced by the prostate, the seminal vesicles, and the vas deferens. These fluids are pushed into the urethra by coordinated muscle contractions, while the bladder neck simultaneously clamps shut to keep semen from traveling backward. Then a second wave of contractions propels the semen forward and out. The prostate sits right at the crossroads of this plumbing, so when it enlarges, problems cascade.

Researchers have identified several ways an enlarged prostate disrupts this sequence. The smooth-muscle cells lining the prostate and bladder neck rely on a signaling pathway involving nitric oxide to relax and contract at the right moments. BPH appears to impair that signaling, which can cause the bladder neck to open when it should stay closed (leading to retrograde ejaculation) or can suppress the coordinated contractions needed to expel semen at all.¹ The autonomic nervous system, which controls these muscles without conscious input, can also become overactive in men with BPH, adding another layer of dysfunction. On top of that, reduced blood flow to the pelvic region from vascular disease, which is common in the same age group, compounds the problem.

How BPH Medications Affect Ejaculation

This is where many men first notice ejaculatory changes, and understandably so. The two main drug classes prescribed for an enlarged prostate each have distinct effects on ejaculation, and combining them roughly multiplies the risk.

Alpha-blockers like tamsulosin relax the smooth muscle in the prostate and bladder neck, easing urinary flow. But that same relaxation can keep the bladder neck from closing properly during ejaculation. In a study tracking men on tamsulosin, the overall rate of ejaculatory dysfunction after 12 weeks was about 13 percent, with decreased pleasure and decreased volume being the most commonly reported issues.³ Tamsulosin seems to cause more ejaculatory trouble than other alpha-blockers. One review estimated the rate of ejaculatory dysfunction at around 10 percent for tamsulosin compared with 0 to 1 percent for other drugs in the same class.⁴

5-alpha reductase inhibitors like finasteride and dutasteride take a different approach: they shrink the prostate over time by blocking the hormone that drives its growth. The trade-off for ejaculation is primarily reduced volume. Finasteride at the dose used for BPH reduces ejaculate volume by about 25 percent.⁵ A review of finasteride’s sexual effects concluded that reduced ejaculatory volume is the only established causal link between the drug and sexual dysfunction, as opposed to the more debated associations with libido and erections.⁶ Men taking dutasteride over longer periods, particularly younger men using it for hair loss, showed progressively declining semen volume and sperm motility with extended use.⁷

When alpha-blockers and 5-alpha reductase inhibitors are prescribed together, ejaculatory dysfunction becomes substantially more likely. A meta-analysis found the odds of ejaculatory problems were about 3.75 times higher with combination therapy compared to alpha-blockers alone, and about 2.75 times higher compared to 5-alpha reductase inhibitors alone.⁸ This is worth discussing with your doctor, because urinary symptom improvement on combination therapy can be meaningful, but so is the hit to ejaculatory function. It is a genuine tradeoff, not a minor footnote.

What Traditional Prostate Surgery Does to Ejaculation

Transurethral resection of the prostate (TURP) has been the standard surgical treatment for decades, and it reliably improves urinary flow. Its effect on ejaculation is also well documented and much more dramatic than medication. The procedure works by removing prostate tissue that is squeezing the urethra, but in doing so, it typically destroys the bladder neck’s ability to close during ejaculation. The result is retrograde ejaculation in a large majority of men. One review estimated the rate of ejaculatory dysfunction after surgery at about 65 percent.⁴

A prospective study measuring ejaculatory function scores before and after TURP found a significant worsening, and men reported considerable bother from the change.⁹ Retrograde ejaculation after TURP is usually permanent, and for men who are not actively trying to conceive, many urologists frame it as harmless. But “harmless” undersells the psychological impact for some men. Orgasm still occurs, but the absence of visible ejaculate can feel deeply unsettling, and can affect sexual confidence and relationship dynamics.¹⁰

There is some surgical nuance here. Modified TURP techniques that deliberately preserve the bladder neck have shown lower rates of retrograde ejaculation in the months after surgery compared with standard TURP.¹¹ If preserving ejaculation matters to you, it is worth asking your surgeon whether a bladder-neck-sparing approach is feasible given your anatomy and degree of obstruction.

Newer Procedures Designed to Preserve Ejaculation

A major reason newer minimally invasive treatments have gained traction is precisely because they tend to leave ejaculatory function intact. For men who want symptom relief without the near-certainty of retrograde ejaculation that comes with TURP, these options are worth understanding.

The prostatic urethral lift (marketed as UroLift) uses small implants to physically pin open the obstructing prostate tissue, creating a wider channel for urine without removing or destroying tissue. In follow-up studies, ejaculatory and erectile function were preserved in essentially every patient. No cases of retrograde ejaculation were reported. European urology guidelines now strongly recommend it for men who want to preserve ejaculation, provided their prostate is under a certain size and does not have a prominent middle lobe.¹² An earlier study confirmed the same finding: no patient reported retrograde ejaculation at any follow-up visit, and significant improvement in urinary symptoms was achieved without degrading sexual function.¹³

Water vapor thermal therapy (Rezūm) uses steam injections to destroy excess prostate tissue. It occupies a middle ground: urinary improvement is robust, and ejaculatory function is largely maintained. A systematic review and meta-analysis found no statistically significant change from baseline in ejaculatory function scores at any follow-up point from one month out to two years.¹⁴ A five-year follow-up study confirmed that ejaculatory bother scores remained stable through the full duration, and men without pre-existing sexual dysfunction before the procedure largely maintained their function over the long term.¹⁵

When Rezūm was compared head-to-head with an ejaculation-sparing laser technique in a small early study, about 83 percent of Rezūm patients maintained ejaculation at three months, compared with 60 percent of those who had the laser procedure.¹⁶ These are early results from a small group, so the numbers could shift as more data come in. Still, both procedures performed far better for ejaculation than traditional TURP.

These newer options come with trade-offs of their own. Their urinary symptom improvement is sometimes more modest than TURP, and a percentage of men eventually need a second procedure. But for men who rank ejaculatory preservation highly, they represent a genuine alternative that did not exist a generation ago.

The Shared Vascular Problem

One underappreciated angle is that BPH, erectile dysfunction, and ejaculatory problems share overlapping root causes beyond just the prostate getting bigger. Research increasingly points to vascular dysfunction as a common driver. The same cardiovascular risk factors that lead to heart disease, including high blood pressure, diabetes, high cholesterol, and atherosclerosis, are also linked to the development and severity of both urinary symptoms and sexual dysfunction in aging men.¹⁷

The connection makes anatomical sense. The prostate, the erectile tissue of the penis, and the muscles involved in ejaculation all depend on healthy blood flow and properly functioning smooth muscle. When blood vessels stiffen and blood flow diminishes from metabolic disease, all three systems suffer. A review of the evidence noted that the association between urinary symptoms and erectile dysfunction is well established across multiple large studies, and that the metabolic syndrome appears to be a key factor driving both.¹⁸

This has practical implications. If you are dealing with both urinary and sexual symptoms, addressing cardiovascular risk factors like weight, blood sugar, and cholesterol is not just good general health advice; it may specifically help both sets of symptoms. It also means that a man who notices ejaculatory changes should not automatically blame his prostate alone, particularly if he has untreated metabolic issues.

Pelvic Floor Exercises and Tadalafil

Beyond the standard BPH medications and surgeries, two approaches have shown some promise for protecting or even improving ejaculatory function. Tadalafil, the same drug used for erectile dysfunction, is now approved in many countries for treating urinary symptoms of BPH as well. Because it works through the nitric oxide pathway, it can improve both urinary flow and sexual function simultaneously, which is a meaningful advantage over alpha-blockers or 5-alpha reductase inhibitors that may worsen ejaculation. Targeted pelvic floor exercises have also shown potential to safeguard ejaculatory function in men with urinary symptoms.¹⁹

Pelvic floor training in men is far less discussed than it is in women, but the muscles involved in ejaculatory force and bladder neck closure are skeletal muscles that respond to exercise. Strengthening them will not reverse damage from surgery, but for men with mild symptoms or those trying to maintain function alongside medication, it represents a low-risk option worth trying.

Semen Volume and Fertility Concerns

For men still interested in fathering children, the ejaculatory effects of BPH and its treatments take on additional urgency. Reduced semen volume, whether from the condition itself or from medications like finasteride, does not necessarily mean infertility. The finasteride data showed that while the drug significantly reduced semen volume and other parameters, the values did not fall below the thresholds associated with impaired fertility in most men.⁶ Dutasteride over longer treatment durations is a different story, with progressively worsening semen parameters raising concerns about persistent effects.⁷

An interesting finding from a study of middle-aged men was that semen quality declined in those with urinary symptoms and prostate enlargement, but this did not appear to be driven by hormonal changes. Testosterone and estradiol levels did not differ between men with and without urinary symptoms, and there was no correlation between hormone levels and semen parameters.²⁰ The mechanical obstruction and local tissue changes from BPH seem to be the more direct culprits, rather than a systemic hormonal shift.

Retrograde ejaculation after TURP creates the most significant fertility barrier, since semen enters the bladder rather than exiting the body. For men in this situation who want to conceive, sperm can sometimes be recovered from urine collected after orgasm and used for assisted reproduction. But it is a cumbersome process and far from guaranteed. This is one of the strongest arguments for discussing ejaculatory preservation with your urologist before committing to a treatment plan, particularly if future fertility is even a remote consideration.

Does Frequent Ejaculation Protect the Prostate

A common question that runs in the other direction is whether ejaculating more often can prevent prostate problems. The idea has some intuitive appeal, and it circulates widely online, usually linked to studies about prostate cancer risk. But the evidence for a connection between ejaculation frequency and BPH-related urinary symptoms is thin. An epidemiological study looking at this specific question found no association between ejaculation frequency in early adulthood and the later development of urinary symptoms.²¹ In other words, ejaculating more or less frequently when you are younger does not seem to influence whether you develop bothersome prostate enlargement later. The prostate cancer data is a separate question with separate evidence, and it should not be conflated with BPH.

For men already experiencing urinary symptoms, changes in ejaculatory frequency are often a consequence of the condition rather than a cause. Discomfort, reduced pleasure, or the psychological weight of sexual changes can naturally lead to less sexual activity. Addressing the underlying prostate issue tends to be more productive than trying to adjust ejaculatory habits as a preventive or therapeutic strategy.